{"slideshow_credits": null, "snippet": "Companies are rushing to win approval for a drug mimicking the effects of a rare gene mutation linked with astoundingly low LDL cholesterol levels, and many heart researchers are bracing for a blockbuster.", "abstract": "Pharmaceutical companies are rushing to win approval for a drug mimicking effects of a rare gene mutation, which drives LDL cholesterol levels to new lows and prevents heart attacks; Amgen, Pfizer and Sanofi have drugs in clinical trials and report that their results, so far, are exciting (Series: Genetic Connections).", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Gina", "role": "reported", "lastname": "KOLATA", "rank": 1, "organization": ""}], "original": "By GINA KOLATA", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/07/10/health/rare-mutation-prompts-race-for-cholesterol-drug.html", "lead_paragraph": "Companies are rushing to win approval for a drug mimicking the effects of a rare gene mutation linked with astoundingly low LDL cholesterol levels, and many heart researchers are bracing for a blockbuster.", "headline": {"print_headline": "Rare Mutation Ignites Race for Cholesterol Drug", "main": "Rare Mutation Ignites Race for Cholesterol Drug", "content_kicker": "Genetic Connections", "kicker": "Genetic Connections"}, "_id": "51dcd9667e0d9c0839d2ee96", "word_count": "1966", "multimedia": [{"height": 126, "url": "images/2013/07/10/us/jpHEART-1/jpHEART-1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/07/10/us/jpHEART-1/jpHEART-1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 397, "url": "images/2013/07/10/us/jpHEART-1/jpHEART-1-articleLarge.jpg", "legacy": {"xlarge": "images/2013/07/10/us/jpHEART-1/jpHEART-1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "397"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/07/10/us/jpHEART2/jpHEART2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/07/10/us/jpHEART2/jpHEART2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-07-10T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Cholesterol", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Genetics and Heredity", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Heart", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Amgen Inc", "is_major": "Y", "rank": "5"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "Y", "rank": "6"}, {"name": "organizations", "value": "Sanofi SA", "is_major": "Y", "rank": "7"}, {"name": "subject", "value": "Biotechnology", "is_major": "N", "rank": "8"}, {"name": "subject", "value": "Series", "is_major": "Y", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}